The EMPIRIC Institute — which stands for excellence in medicine, patient impact research, innovation and care — was formed to measure and research patient impact within Patient Square Capital’s portfolio companies, according to a July 27 news release.
Dr. Baggett will lead the institute as managing director, in addition to serving as chair and head of patient impact. He also serves on the Baltimore-based Johns Hopkins Bloomberg School of Public Health’s advisory board and as a board member for the Prostate Cancer Foundation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
